-
1
-
-
0025204548
-
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
-
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
-
(1990)
Nature
, vol.348
, pp. 334-336
-
-
Hockenbery, D.1
Nunez, G.2
Milliman, C.3
Schreiber, R.D.4
Korsmeyer, S.J.5
-
2
-
-
0027485461
-
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
-
Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
-
(1993)
Cell
, vol.75
, pp. 241-251
-
-
Hockenbery, D.M.1
Oltvai, Z.N.2
Yin, X.M.3
Milliman, C.L.4
Korsmeyer, S.J.5
-
3
-
-
0030979773
-
Double identity for proteins of the Bcl-2 family
-
Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-6.
-
(1997)
Nature
, vol.387
, pp. 773-776
-
-
Reed, J.C.1
-
4
-
-
0031918223
-
BCL-2 family: Regulators of cell death
-
Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395-419.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 395-419
-
-
Chao, D.T.1
Korsmeyer, S.J.2
-
6
-
-
0028089807
-
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 α in association with suppression of apoptosis
-
May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 α in association with suppression of apoptosis. J Biol Chem 1994;269:26865-70.
-
(1994)
J Biol Chem
, vol.269
, pp. 26865-26870
-
-
May, W.S.1
Tyler, P.G.2
Ito, T.3
Armstrong, D.K.4
Qatsha, K.A.5
Davidson, N.E.6
-
7
-
-
0029913172
-
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
-
Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 1996;56:1851-4.
-
(1996)
Cancer Res
, vol.56
, pp. 1851-1854
-
-
Blagosklonny, M.V.1
Schulte, T.2
Nguyen, P.3
Trepel, J.4
Neckers, L.M.5
-
8
-
-
0033499801
-
BCL-2 is phosphorylated and inactivated by an ASKI/Jun N-terminal protein kinase pathway normally activated at G (2)/M
-
Yamamoto K, Ichijo H, Korsmeyer SJ. BCL-2 is phosphorylated and inactivated by an ASKI/Jun N-terminal protein kinase pathway normally activated at G (2)/M. Mol Cell Biol 1999;19:8469-78.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 8469-8478
-
-
Yamamoto, K.1
Ichijo, H.2
Korsmeyer, S.J.3
-
9
-
-
0033774291
-
The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2
-
Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000;2:819-25.
-
(2000)
Nat Cell Biol
, vol.2
, pp. 819-825
-
-
Ojala, P.M.1
Yamamoto, K.2
Castanos-Velez, E.3
Biberfeld, P.4
Korsmeyer, S.J.5
Makela, T.P.6
-
10
-
-
0030959304
-
Bcl-2 phosphorylation required for anti-apoptosis function
-
Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 1997;272:11671-3.
-
(1997)
J Biol Chem
, vol.272
, pp. 11671-11673
-
-
Ito, T.1
Deng, X.2
Carr, B.3
May, W.S.4
-
11
-
-
0031671581
-
Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein
-
Basu A, Haldar S. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol 1998;13:659-64.
-
(1998)
Int J Oncol
, vol.13
, pp. 659-664
-
-
Basu, A.1
Haldar, S.2
-
12
-
-
15644381250
-
Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress- activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1
-
Maundrell K, Antonsson B, Magnenat E, et al. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem 1997;272:25238-42.
-
(1997)
J Biol Chem
, vol.272
, pp. 25238-25242
-
-
Maundrell, K.1
Antonsson, B.2
Magnenat, E.3
-
13
-
-
0029902549
-
30 kDa phosphorylated form of Bcl-2 protein in human colon
-
Guan RJ, Moss SF, Arber N, Krajewski S, Reed JC, Holt PR, 30 kDa phosphorylated form of Bcl-2 protein in human colon. Oncogene 1996;12:2605-9.
-
(1996)
Oncogene
, vol.12
, pp. 2605-2609
-
-
Guan, R.J.1
Moss, S.F.2
Arber, N.3
Krajewski, S.4
Reed, J.C.5
Holt, P.R.6
-
14
-
-
0028540185
-
Antiapoptosis potential of bcl-2 oncogene by dephosphorylation
-
Haldar S, Jena N, Croce CM. Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem Cell Biol 1994;72:455-62.
-
(1994)
Biochem Cell Biol
, vol.72
, pp. 455-462
-
-
Haldar, S.1
Jena, N.2
Croce, C.M.3
-
15
-
-
0034988898
-
Unwinding the loop of Bcl-2 phosphorylation
-
Blagosklonny MV. Unwinding the loop of Bcl-2 phosphorylation. Leukemia 2001;15:869-74.
-
(2001)
Leukemia
, vol.15
, pp. 869-874
-
-
Blagosklonny, M.V.1
-
16
-
-
0034730511
-
Vinblastine-induced phosphorylation of Bcl-2 and Bel-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade
-
Fan M, Goodwin M, Vu T, Brantley-Finley C, Gaarde WA, Chambers TC. Vinblastine-induced phosphorylation of Bcl-2 and Bel-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J Biol Chem 2000;275:29980-5.
-
(2000)
J Biol Chem
, vol.275
, pp. 29980-29985
-
-
Fan, M.1
Goodwin, M.2
Vu, T.3
Brantley-Finley, C.4
Gaarde, W.A.5
Chambers, T.C.6
-
17
-
-
0035847092
-
c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway
-
Bagowski CP, Xiong W, Ferrell JE Jr. c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway. J Biol Chem 2001;276:1459-65.
-
(2001)
J Biol Chem
, vol.276
, pp. 1459-1465
-
-
Bagowski, C.P.1
Xiong, W.2
Ferrell Jr., J.E.3
-
18
-
-
0032529660
-
Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells
-
Ling YH, Yang Y, Tornos C, Singh B, Perez-Soler R. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res 1998;58:3633-40.
-
(1998)
Cancer Res
, vol.58
, pp. 3633-3640
-
-
Ling, Y.H.1
Yang, Y.2
Tornos, C.3
Singh, B.4
Perez-Soler, R.5
-
19
-
-
0034145438
-
Regulation of Bcl-2 phosphorylation by stress response kinase pathway
-
Basu A, You SA, Haldar S. Regulation of Bcl-2 phosphorylation by stress response kinase pathway. Int J Oncol 2000;16:497-500.
-
(2000)
Int J Oncol
, vol.16
, pp. 497-500
-
-
Basu, A.1
You, S.A.2
Haldar, S.3
-
21
-
-
0038360113
-
-
Philadelphia: Lippincott-Raven
-
American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
-
(1997)
AJCC Cancer Staging Manual. 5th Ed.
-
-
-
22
-
-
0030901628
-
Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2
-
Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 2000;386:728-31.
-
(2000)
Nature
, vol.386
, pp. 728-731
-
-
Shibasaki, F.1
Kondo, E.2
Akagi, T.3
McKeon, F.4
-
23
-
-
0031041089
-
Bcl-X(L), a member of the Bcl-2 family, can inhibit many forms of programmed cell death
-
Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. Bcl-X(L), a member of the Bcl-2 family, can inhibit many forms of programmed cell death. EMBO J 1997;16:968-77.
-
(1997)
EMBO J
, vol.16
, pp. 968-977
-
-
Chang, B.S.1
Minn, A.J.2
Muchmore, S.W.3
Fesik, S.W.4
Thompson, C.B.5
-
24
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
25
-
-
0013886333
-
Evaluation of survival data and two new rank order statistics arising in its consideration
-
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 163-170
-
-
Mantel, N.1
-
26
-
-
0032514914
-
Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest
-
Scatena CD, Stewart ZA, Mays D, et al. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 1998;273:30777-91.
-
(1998)
J Biol Chem
, vol.273
, pp. 30777-30791
-
-
Scatena, C.D.1
Stewart, Z.A.2
Mays, D.3
-
27
-
-
0032145442
-
"Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome C and apoptosis
-
Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome C and apoptosis. Cancer Res 1998;58:3202-8.
-
(1998)
Cancer Res
, vol.58
, pp. 3202-3208
-
-
Fang, G.1
Chang, B.S.2
Kim, C.N.3
Perkins, C.4
Thompson, C.B.5
Bhalla, K.N.6
-
28
-
-
0030023858
-
Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells
-
Soltys BJ, Guputa RS. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp Cell Res 1996;222:16-27.
-
(1996)
Exp Cell Res
, vol.222
, pp. 16-27
-
-
Soltys, B.J.1
Guputa, R.S.2
-
29
-
-
0029938724
-
Regulation of cell division cycle progression by bcl-2 expressions potential mechanism for inhibition of programmed cell death
-
Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bcl-2 expressions potential mechanism for inhibition of programmed cell death. J Exp Med 1996;183:2219-26.
-
(1996)
J Exp Med
, vol.183
, pp. 2219-2226
-
-
Mazel, S.1
Burtrum, D.2
Petrie, H.T.3
|